BioCentury
ARTICLE | Clinical News

Bupivacaine collagen sponge: Phase III started

September 28, 2015 7:00 AM UTC

Innocoll began the double-blind, placebo-controlled, U.S. MATRIX-2 trial to evaluate 3 XaraColl implants each containing 100 mg bupivacaine in about 300 patients with a unilateral inguinal hernia unde...